Palleiko Benjamin L (CIK 1366244) reported 41 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-11). Recent activity: Sell KALV (479,989 shares), Buy KALV (2,419 shares), Sell KALV (1,129 shares), Buy KALV (7,120 shares), Sell KALV (3,322 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 479,989 | $0 |
| 2026-05-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 2,419 | $0 |
| 2026-05-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 1,129 | $30,212 |
| 2026-05-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 7,120 | $0 |
| 2026-05-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 3,322 | $88,731 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 20,312 | $0 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 9,550 | $193,066 |
| 2026-03-10 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 15,625 | $0 |
| 2026-03-10 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 6,693 | $107,623 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 23,250 | $0 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 10,034 | $156,229 |
| 2026-02-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 1,038 | $15,570 |
| 2026-02-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 2,419 | $0 |
| 2026-02-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 7,120 | $0 |
| 2026-02-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 3,354 | $52,658 |
| 2025-12-09 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 15,625 | $0 |
| 2025-12-09 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 7,294 | $120,424 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 23,250 | $0 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 10,940 | $147,143 |
| 2025-11-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 9,364 | $0 |
| 2025-11-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 4,466 | $64,668 |
| 2025-11-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 7,120 | $0 |
| 2025-11-13 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 3,328 | $38,438 |
| 2025-09-09 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Buy | 15,625 | $0 |
| 2025-09-09 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF EXECUTIVE OFFICER | Sell | 7,294 | $115,537 |
Source: SEC Form 4 filings · as of 2026-06-11